文献速递消化内镜消化道肿瘤与早癌

门诊环境下内镜黏膜下剥离术切除大型结直肠肿瘤:瑞典单中心660例手术系列

Endoscopic submucosal dissection for removal of large colorectal neoplasias in an outpatient setting: a single-center series of 660 procedures in Sweden.
PubMed 文献 · Gastrointest Endosc · 2022-02-22

该单中心回顾性系列评估了2014至2020年间660例结直肠内镜黏膜下剥离术(ESD),其中612例(92.7%)按门诊计划安排。整块切除率93.9%,R0切除率79.4%,全层穿孔率5.8%,30天内因出血、腹部压痛等原因就医者7.0%。作者结论认为,在严格筛选的患者中,结直肠ESD可安全地在门诊环境下进行。

要点

  • 660例结直肠ESD中612例(92.7%)按门诊计划安排,33例非计划入院。
  • 整块切除620例(93.9%),R0切除492例(79.4%)。
  • 全层穿孔38例(5.8%),35例(92.1%)内镜处理,3例(7.9%)需急诊手术。

核心结论

  • 作者结论认为,在严格筛选的患者中,结直肠病变的ESD可安全地在门诊环境下进行。

研究设计与样本

  • 单中心回顾性评估2014年至2020年间660例结直肠ESD手术。
  • 所有转诊至该单位、无深部浸润征象且大于20 mm的早期结直肠肿瘤患者均考虑适合行ESD。

主要发现

  • 660例病变中,近端结肠323例(48.9%),远端结肠102例(15.5%),直肠235例(35.6%)。
  • 病变中位大小38 mm(四分位距30-50),中位手术时间70分钟(四分位距45-115)。
  • 整块切除620例(93.9%);R0切除492例整块切除(79.4%),Rx切除124例(20.0%),R1切除4例(0.6%)。
  • 低级别异型增生473例(71.7%),高级别异型增生144例(21.8%),腺癌34例(5.1%)。
  • 612例(92.7%)按门诊计划安排,其中33例非计划入院;48例(7.3%)按住院计划安排。

临床怎么用

  • 原文结论认为,在严格筛选的患者中,结直肠ESD可安全地在门诊环境下进行。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is a technique developed in Japan for the removal of large lesions in the GI tract. Because of the complexity of the technique, implementation in Western health care has been slow. An ESD procedure is usually followed by hospital admission. Our aim was to investigate if ESD of colorectal lesions can be performed in an outpatient setting. METHODS: Six hundred sixty colorectal ESD procedures between 2014 and 2020 were evaluated retrospectively. All patients referred to the unit with an early colorectal neoplasm >20 mm without signs of deep invasion were considered eligible for an ESD procedure. RESULTS: Of 660 lesions, 323 (48.9%) were localized in the proximal colon, 102 (15.5%) in the distal colon, and 235 (35.6%) in the rectum. Median lesion size was 38 mm (interquartile range, 30-50) and median procedure duration 70 minutes (interquartile range, 45-115). En-bloc resection was achieved in 620 cases (93.9%). R0 resection was achieved in 492 en-bloc resections (79.4%), whereas the number of Rx and R1 resections was 124 (20.0%) and 4 (.6%), respectively. Low-grade dysplasia was found in 473 cases (71.7%), high-grade dysplasia in 144 (21.8%), and adenocarcinoma in 34 (5.1%). Six hundred twelve procedures (92.7%) were scheduled as outpatient, and 33 of these underwent unplanned admission. Forty-eight cases (7.3%) were planned as inpatient procedures. The rate of full wall perforation was 38 (5.8%), in which 35 (92.1%) were managed endoscopically and 3 patients (7.9%) required emergency surgery. Forty-six patients (7.0%) sought medical attention within 30 days because of bleeding (21 [3.2%]), abdominal tenderness (16 [2.4%]), and other reasons (9 [1.4%]). Twenty-four of these patients were admitted for observation for a median of 2 days (range, 1-7). Ten of these patients were treated with antibiotics, and 6 patients required blood transfusion. None required additional surgery. CONCLUSIONS: ESD of colorectal lesions can be safely performed in an outpatient setting in a well-selected patient.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Tidehag V, Törnqvist B, Pekkari K, et al. Endoscopic submucosal dissection for removal of large colorectal neoplasias in an outpatient setting: a single-center series of 660 procedures in Sweden. Gastrointest Endosc. 2022. PMID: 35217016. doi:10.1016/j.gie.2022.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。